StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co (BMY) income statement

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3032% below fair value
$59.56−1.79 (-2.92%)

Close on Nov 18, 2026Market cap $121.75BP/E 13.2Yield 4.18%

Bristol Myers Squibb Co income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
69.2%
Operating margin
–
Net margin
18.5%
Return on equity, FY2025
40.5%

Financial strength

Current ratio
1.59
Debt to equity
1.83
Debt to assets
48.3%
Cash to current liabilities
51.1%

Valuation

P/E ratio
13.2
Price to sales
2.43
Price to book
5.20
Dividend yield
4.18%

See a number that looks wrong?